Recursion Pharma's AI-powered therapy reduces colon growth in a rare disease trial

Recursion Pharma , which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths in the colon in patients with a rare ...

Recursion Pharmaceuticals stock surges after positive FAP trial data

Investing.com -- Recursion Pharmaceuticals (NASDAQ:RXRX) stock rose 7% Monday following positive Phase 2 trial results for its experimental drug REC-4881 in familial adenomatous polyposis (FAP), a ...
Le Lézard

Recordati Rare Diseases Showcases Real-World Evidence Studies That Advance Understanding of Castleman Disease (CD) at the American Society of Hematology (ASH) Annual Meeting

Recordati Rare Diseases Inc. today announced the presentation of new data detailing advances in the understanding of Castleman disease (CD), a group of rare immune system disorders characterized by ...

Cathie Wood's weekly recap: heads turn to AI, biotech; sells communication names

Cathie Wood’s ARK Invest executed a busy week of portfolio adjustments across its ETFs, with several high-conviction ...

After Texas ruling, Trump and Republicans head to 2026 with a redistricting edge

Trump has prompted a redistricting race as he tries to maintain Republican control of the House in the 2026 elections.